dental sector
dental implant sector
dental implant product
orthopaedics sector
dental implants
Dissemination of Agluna
problem of post-operative implant infection
global market opportunity
global problem
Phase
EU limb salvage market
wider global orthopaedic market
successful commercialisation of Agluna
Implant related infections
commercial application of Agluna
anti-microbial surface technology
account of EU
incidence of post-operative infection
global markets
market entry strategy
proven innovative silver ion
proven technology utilising silver ions
surface of implanted devices
substantiated business plan
project objective
investment requirements
antibiotic-resistant bacterial strains
limited reported bacterial resistance
well-known biocide
clinical use
subsequent expected outcome
principal deliverable
solutions
growing concern
socio-economic costs
peri-implantitis
months
duration
formation of biofilm
prevention
control of
significant reduction
range of medical device sectors
scope
international regulatory pathways
human proof of concept study
time
approaches
size
basis
confirmation